Duke UniversityPratt School of Engineering: New Pharmaceutical Target Reverses Osteoporosis in Mice
August 22, 2019
August 22, 2019
DURHAM, North Carolina, Aug. 22 [TNSscienceresearch] -- Duke University's Pratt School of Engineering issued the following news release:
* * *
- Duke researchers show that activating the adenosine receptor A2B not only halts but reverses bone deterioration in mouse models of osteoporosis
* * *
Biomedical engineers at Duke University have discovered a pharmaceutical target that, when activated, can reverse bone degradation caused by osteoporosis . . .
* * *
- Duke researchers show that activating the adenosine receptor A2B not only halts but reverses bone deterioration in mouse models of osteoporosis
* * *
Biomedical engineers at Duke University have discovered a pharmaceutical target that, when activated, can reverse bone degradation caused by osteoporosis . . .